15 research outputs found

    The influence of executive capacity on selective attention and subsequent processing

    Get PDF
    Recent investigations that suggest selective attention (SA) is dependent on top-down control mechanisms lead to the expectation that individuals with high executive capacity (EC) would exhibit more robust neural indices of SA. This prediction was tested by using event-related potentials (ERPs) to examine differences in markers of information processing across 25 subjects divided into two groups based on high vs. average EC, as defined by neuropsychological test scores. Subjects performed an experimental task requiring SA to a specified color. In contrast to expectation, individuals with high and average EC did not differ in the size of ERP indices of SA: the anterior Selection Positivity (SP) and posterior Selection Negativity (SN). However, there were substantial differences between groups in markers of subsequent processing, including the anterior N2 (a measure of attentional control) and the P3a (an index of the orienting of attention). EC predicted speed of processing at both early and late attentional stages. Individuals with lower EC exhibited prolonged SN, P3a, and P3b latencies. However, the delays in carrying out SA operations did not account for subsequent delays in decision making, or explain excessive orienting and reduced attentional control mechanisms in response to stimuli that should have been ignored. SN latency, P3 latency, and the size of the anterior N2 made independent contributions to the variance of EC. In summary, our findings suggest that current views regarding the relationship between top-down control mechanisms and SA may need refinement

    Beyond Prognosis Communication: Exploring The Existential Dimensions Of Palliative Care Conversations With Adults With Advanced Cancer

    No full text
    Communication about prognosis is integral to effective palliative care. However, prognosis communication often entails considering mortality, which can trigger existential questions. We understand very little about how existential experience is communicated in palliative care conversations. To fill this gap, this dissertation addresses the following aims: (1) Clarify the concept of the existential experience within the context of adults with advanced cancer (Chapter 2); (2) Describe how patients, families, and clinicians communicate about existential experience in palliative care conversations (Chapter 3); and (3) Explore the intersection between prognosis communication and existential dimensions of conversation (Chapter 4). To accomplish Aim 1, we synthesized published qualitative literature regarding how adults with advanced cancer describe their existential experience. Using Rodgers’ evolutionary method of concept analysis, we conceptualize existential experience as a dynamic state, preceded by confronting mortality, defined by diverse reactions to shared existential challenges related to parameters of existence (body, time, others, and death), resulting in a dialectical movement between existential suffering and joy. To address Aims 2 and 3, we analyzed a randomly selected subset of an existing Palliative Care Communication Research Initiative (PCCRI) study dataset. PCCRI data includes verbatim transcripts of inpatient palliative care consultations with adults with advanced cancer. Using a qualitative descriptive approach, we found that overall, existential communication was woven within palliative care conversations, and related to key themes of: 1) Time as a pressing boundary; 2) Maintaining a coherent self; and 3) Connecting with others. In Chapter 4, we took a mixed methods approach, quantitatively stratifying the study sample by levels of prognosis communication and qualitatively describing existential dimensions of conversations within and across none, low, and high levels of prognosis communication. We found existential and prognosis communication were deeply interconnected. Additionally, existential communication was more common within conversations with higher levels of prognosis communication, representing an existential shift compared to the more physical focus of conversations with no prognosis communication. This dissertation generates new knowledge about how existential experience is communicated during naturally-occurring palliative care conversations. Our findings have implications for improving how we communicate with, and care for, individuals with advanced cancer and their families

    Acceptability of psilocybin‐assisted group therapy in patients with cancer and major depressive disorder: Qualitative analysis

    No full text
    International audienceAbstractBackgroundThe present study explored the acceptability of psilocybin‐assisted group therapy from the perspective of patients with cancer and depression who participated in a clinical trial assessing the safety and efficacy of this novel intervention.MethodsGuided by the conceptual framework of acceptability, the authors conducted semi‐structured interviews with participants of the psilocybin trial. Data were analyzed using template and thematic analyses.ResultsParticipants’ (n = 28) perspectives on the acceptability of the group and simultaneous sessions was generally positive, both in terms of safety and efficacy: first, the groups contributed to increase participants’ sense of safety and preparedness as they were engaging in the therapy; and second, the groups fostered a sense of connection and of belonging, which served to enrich and deepen the meaning of participants’ experience, ultimately opening a dimension of self‐transcendence and compassion. Other subthemes related to factors influencing the acceptability of the group approach included: 1) the importance of the therapeutic framework, 2) the complementary value of individual sessions, 3) disruptive factors related to the group and/or simultaneous setting, and 4) opportunities and challenges related to group size and how to structure interactions.ConclusionsThis study enhances understanding of what promotes acceptability of the psilocybin‐assisted therapy group model for the treatment of MDD in cancer patients.Plain Language Summary We conducted exit interviews with participants of a phase 2 trial of psilocybin‐assisted therapy (PAT) conducted in a community cancer center, to assess the acceptability of a novel psilocybin delivery model combining simultaneous individual therapy and group sessions. Our findings support the acceptability of this intervention and suggest that in addition to being feasible, it might also enhance participants’ perceived safety and efficacy compared to uniquely individual or group delivery models of PAT. Our analysis highlights critical factors conditioning acceptability and suggests new ways PAT may be scaled and integrated into cancer care. </jats:sec
    corecore